Skip to main content

Table 6 The effect of low-carbohydrate diet for the thresholds

From: Which is the proper reference tissue for measuring the change in FDG PET metabolic volume of cardiac sarcoidosis before and after steroid therapy?

  

Pre-therapy

 

p value

During therapy

 

p value

Region

LCHD (+)

(n = 23)

LCHD (−)

(n = 15)

 

LCHD (+)

(n = 23)

LCHD (−)

(n = 15)

 

SUVmean + 3SD

Liver 1

3.5 ± 0.4

3.5 ± 0.4

0.59

3.7 ± 0.7

4.0 ± 0.5

0.18

SUVmax

Liver 2

3.5 ± 0.4

3.5 ± 0.4

0.71

3.8 ± 0.7

3.9 ± 0.6

0.37

DA

2.1 ± 0.3

2.2 ± 0.3

0.35

2.2 ± 0.4

2.3 ± 0.3

0.32

SUVmean

Liver 2

2.7 ± 0.3

2.7 ± 0.3

0.78

2.9 ± 0.5

3.1 ± 0.4

0.13

DA

1.9 ± 0.3

2.0 ± 0.2

0.14

1.9 ± 0.4

2.1 ± 0.2

0.29

  1. SD standard deviation, LCHD low-carbohydrate diet, SUV standardized uptake value, Liver 1 SUV in the liver by semi-automated method, Liver 2 SUV in the liver by manual process, DA descending aorta